Core Scientific, Inc. Common Stock
CORZ
CORZ was delisted on the 30th of December, 2022.
89 hedge funds and large institutions have $5.01M invested in Core Scientific, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 76 closing their positions.
151% more call options, than puts
Call options by funds: $143K | Put options by funds: $57K
32% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 22
35% less funds holding
Funds holding: 137 → 89 (-48)
62% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 76
96% less capital invested
Capital invested by funds: $121M → $5.01M (-$116M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$6.79M |
| 2 |
Millennium Management
New York
|
+$904K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$673K |
| 4 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$574K |
| 5 |
HF
HRT Financial
New York
|
+$275K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$21.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$16.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16M |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.15M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$6.07M |
CORZ Hedge Fund Activity: Q4 2022 in Review
89 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Core Scientific, Inc. Common Stock (CORZ) for Q4 2022, worth a combined $5.01M — down 96% from $121M a quarter earlier.
Sellers outnumbered buyers: 76 funds closed out of CORZ and 29 opened new positions — a net loss of 47 holders — while 22 trimmed existing stakes and 15 added.
The largest buyer was Mirae Asset Global Investments, adding an estimated $6.79M. The largest seller was BlackRock, exiting entirely with an estimated $21.5M sold.
- 89 institutional investors held Core Scientific, Inc. Common Stock (CORZ) as of Q4 2022, down from 137 in Q3 2022.
- Funds reported $5.01M of Core Scientific, Inc. Common Stock stock for Q4 2022, down 96% quarter-over-quarter.
- 29 funds opened new Core Scientific, Inc. Common Stock positions in Q4 2022 and 76 closed out, a net change of -47 holders.
- The largest Core Scientific, Inc. Common Stock buyer in Q4 2022 was Mirae Asset Global Investments, an estimated $6.79M added.
- The largest Core Scientific, Inc. Common Stock seller in Q4 2022 was BlackRock, an estimated $21.5M sold.
Based on aggregated 13F filings for Q4 2022.